17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases

US9096639B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Ulrich Klar · Berlin, DE
• Wolfgang Schwede · Berlin, DE
• Carsten Möller · Berlin, DE
• Andrea Rotgeri · Berlin, DE
• Ursula Krenz · Leichlingen, DE

Key dates

• Filing date: Jul 7, 2010
• Grant date: Aug 4, 2015
• Expiry date: Mar 21, 2032

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/58
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to 17-hydroxy-13-methyl-17-pentafluoroethyl-11-acyloxyalkylenephenyldodecahydrocyclopenta[a]phenanthren-3-one derivatives of the formula I with progesterone-antagonizing action and to processes for preparation thereof, to use thereof for treatment and/or prophylaxis of disorders and to the use thereof for production of medicaments for treatment and/or prophylaxis of disorders, especially of fibroids of the uterus (myomas, uterine leiomyomas), endometriosis, heavy menstrual bleeds, meningiomas, hormone-dependent breast cancers and complaints associated with the menopause, or for fertility control and emergency contraception.